McKesson Corporation (MCK) Stock Analysis & Winston Score
McKesson Corporation is one of the largest healthcare distribution companies in the United States. It moves medicines, medical supplies, and healthcare products from manufacturers to hospitals, pharmacies, and doctors' offices. Think of McKesson as a giant middleman that makes sure the right drugs and supplies get to the right places across the country. McKesson makes money by buying products in bulk from drug makers and selling them to healthcare providers, earning a small margin on each transaction — which explains the very thin gross margins. It operates primarily in the United States, with some international presence, and generates over $300 billion in annual revenue, making it one of the largest companies in America by sales. Its size and deep relationships with suppliers and customers create a strong competitive position that is hard for smaller rivals to match. The main risk is that pricing pressure from large pharmacy chains and potential changes to drug distribution regulations could squeeze its already narrow margins further.
Winston Score: 55/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (13/30)
- Growth: Exceptional (18/20)
- Cash Flow: Strong (7/10)
- Stability: Good (5/10)
- Valuation: Strong (8/10)
- Ownership: Weak (1/15)
Key Facts
Price: $841.39
Market Cap: $98.5B
Sector: Healthcare
Industry: Medical - Distribution

